JP2001151938A - W/o/w type complex emulsion - Google Patents

W/o/w type complex emulsion

Info

Publication number
JP2001151938A
JP2001151938A JP33735099A JP33735099A JP2001151938A JP 2001151938 A JP2001151938 A JP 2001151938A JP 33735099 A JP33735099 A JP 33735099A JP 33735099 A JP33735099 A JP 33735099A JP 2001151938 A JP2001151938 A JP 2001151938A
Authority
JP
Japan
Prior art keywords
emulsion
aqueous phase
polysaccharide
phase
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP33735099A
Other languages
Japanese (ja)
Other versions
JP4478264B2 (en
Inventor
Kenji Matsuda
賢治 松田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to JP33735099A priority Critical patent/JP4478264B2/en
Publication of JP2001151938A publication Critical patent/JP2001151938A/en
Application granted granted Critical
Publication of JP4478264B2 publication Critical patent/JP4478264B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a W/O/W type complex emulsion that maintains excellent properties for a long time, especially restoration behavior in characteristics at defreezing and feel at use, and is useful for medical applications cosmetic preparations, etc. SOLUTION: This W/O/W type complex emulsion is characterized in that the ratio of the W/O type emulsion to the outer water phase lies in the range of from 30/70 to 80/20 (mass ratio), wherein the W/O type emulsion has an inner water phase comprising a polysaccharide with a sulfonic group and/or a carboxyl group in a molecule and an oil phase at a ratio of 50/50 to 90/10 (mass ratio). As the polysaccharide, an acidic mucopolysaccharide, especially chondroitin 4-sulfate, heparin, a heparin-like substance, iota-carrageenan, hyaluronic acid are preferable.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、医薬用や化粧料製
剤等として有用なW/O/W型複合エマルションに関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a W / O / W composite emulsion useful as a pharmaceutical or cosmetic preparation.

【従来の技術】W/O/W型複合エマルションを生成させる
ためには、分散質となるW/O型エマルションを調製した
後、該W/O型エマルションを外水相に再分散させる必要
がある。しかし、再分散の過程で、W/O型エマルション
の油相の一部が外水相中の親水性界面活性剤によって可
溶化されるため、W/O型エマルションは破壊されやす
く、結果として安定性に優れたW/O/W型複合エマルショ
ンを高い生成率で得ることが困難であった。従来、この
ような再分散工程(2次乳化)中の転相を防止するため
に、1次乳化で内水相に対して油相の割合を高めたW/O型
エマルション(W≦O)の調製が不可欠であった。しか
し、内水相に対して油相の割合を高めたW/O型エマルシ
ョンを用いると、べたつき感が生じ、W/O/W型本来の使
用感が損なわれる問題があった。また、W/O/W型複合エ
マルションは、高い生成率で調製することが難しいばか
りでなく、長期安定性、特に凍結復元性が著しく劣る問
題がある。従来、W/O/W型複合エマルションの安定化方
法がいくつか提案されているが、良好な使用感と長期安
定性特に凍結復元性を同時に解決する手段はなかった。
すなわち、高い生成率でW/O/W型複合エマルション
を製造する従来技術例として、複合粒子(W/O粒子)
同士の合一を防ぐ方法として、特開昭58−18361
1に、外水相に増粘剤として水溶性多糖類を使用する方
法が記載されている。しかしながら、この方法では内水
相の合一は防げず、安定化不十分であり、しかも増粘す
るので使用感が損なわれ、実用的でない。また、特開平
7−118306号公報には、硫酸化多糖を配合したW
/O型乳化組成物が開示されている。しかしながら、こ
の方法では長期安定性(エマルションの粘度維持)が不
十分であるばかりでなく、外相が油であるためべたつき
感があり実用的でない。さらに、特開昭62−2271
2号公報には、内水相に単糖類、二糖類、多糖類及び多
価アルコールから選ばれる1種以上を含有するW/O/W
型乳化香料組成物が開示されている。しかしながら、こ
の方法では安定化のために上記成分を多量に配合しなく
てはならず実用的ではない。
2. Description of the Related Art In order to form a W / O / W type composite emulsion, it is necessary to prepare a W / O type emulsion as a dispersoid and then redisperse the W / O type emulsion in an external aqueous phase. is there. However, during the redispersion process, a part of the oil phase of the W / O emulsion is solubilized by the hydrophilic surfactant in the external aqueous phase, so that the W / O emulsion is easily broken, and as a result stable It was difficult to obtain a W / O / W type composite emulsion having excellent properties at a high production rate. Conventionally, in order to prevent such phase inversion during the redispersion process (secondary emulsification), W / O emulsion (W ≦ O) in which the ratio of the oil phase to the internal aqueous phase was increased by primary emulsification Was essential. However, when a W / O emulsion in which the ratio of the oil phase to the internal aqueous phase is increased is used, there is a problem that sticky feeling is generated and the original feeling of use of the W / O / W type is impaired. Further, the W / O / W type composite emulsion is not only difficult to prepare at a high production rate, but also has a problem that the long-term stability, particularly the freeze-recoverability, is extremely poor. Conventionally, several methods for stabilizing a W / O / W type composite emulsion have been proposed, but there has been no means for simultaneously solving a good feeling in use and long-term stability, especially freeze-recoverability.
That is, as a conventional example of producing a W / O / W type composite emulsion at a high production rate, composite particles (W / O particles)
Japanese Patent Application Laid-Open No. 58-18361 discloses a method for preventing coalescence between two members.
1 describes a method of using a water-soluble polysaccharide as a thickener in an external aqueous phase. However, this method does not prevent coalescence of the internal aqueous phases, is insufficiently stabilized, and further increases the viscosity, which impairs the feeling of use and is not practical. Also, Japanese Patent Application Laid-Open No. Hei 7-118306 discloses W
An / O emulsion composition is disclosed. However, this method is not practical because of not only insufficient long-term stability (maintaining the viscosity of the emulsion) but also a sticky feeling because the external phase is oil. Further, JP-A-62-2271
No. 2 discloses a W / O / W containing one or more selected from monosaccharides, disaccharides, polysaccharides and polyhydric alcohols in an inner aqueous phase.
An emulsified perfume composition is disclosed. However, in this method, a large amount of the above components must be blended for stabilization, which is not practical.

【0002】[0002]

【本発明が解決する課題】本発明は、長期安定性、特に
凍結復元性及び使用感に優れたW/O/W型複合エマルショ
ンを提供する。
DISCLOSURE OF THE INVENTION The present invention provides a W / O / W type composite emulsion which is excellent in long-term stability, in particular, freeze-recoverability and feeling upon use.

【課題を解決するための手段】本発明は、分子内にスル
ホン基及び/又はカルボキシル基を有する多糖類を内水
相に配合することにより、2次乳化で破壊されにくい安
定な高含水W/O型エマルションの調製が可能であること
を見出し、前記W/O型エマルションを分散質とすること
によって、長期安定性、特に凍結復元性に優れるW/O/W
型複合エマルションが高い生成率で得られることを見出
したものである。すなわち、本発明は、分子内にスルホ
ン基及び/又はカルボキシル基を有する多糖類を内水相
に含有することを特徴とするW/O/W型複合エマルショ
ンを提供する。
Means for Solving the Problems The present invention provides a stable high water content W / W which is hardly destroyed by secondary emulsification by blending a polysaccharide having a sulfone group and / or a carboxyl group in a molecule into an internal aqueous phase. It has been found that the preparation of an O-type emulsion is possible, and by using the W / O-type emulsion as a dispersoid, long-term stability, particularly W / O / W excellent in freeze-recoverability.
It has been found that a type composite emulsion can be obtained at a high production rate. That is, the present invention provides a W / O / W type composite emulsion comprising a polysaccharide having a sulfone group and / or a carboxyl group in a molecule in an internal aqueous phase.

【0003】[0003]

【発明の実施の形態】本発明の多糖類を構成する主な単
糖としては、D-グルコサミン、D-ガラクトサミン、D
-グルクロン酸、L-イズロン酸、D-グルコース、D-ガ
ラクトース、D-キシロース等があげられる。本発明の
多糖類は、1種以上の単糖のポリマーであり、スルホン
基又はカルボキシル基は、単糖1分子あたり平均0.4〜5
分子含まれるのが好ましく、より好ましくは0.5〜3分
子、さらに好ましくは0.6〜2分子含まれるのが好まし
い。本発明の多糖類の平均分子量は、好ましくは1,000
〜10,000,000、より好ましくは3,000〜1,000,000、さら
に好ましくは5,000〜500,000である。
DESCRIPTION OF THE PREFERRED EMBODIMENTS The main monosaccharides constituting the polysaccharide of the present invention include D-glucosamine, D-galactosamine,
-Glucuronic acid, L-iduronic acid, D-glucose, D-galactose, D-xylose and the like. The polysaccharide of the present invention is a polymer of one or more monosaccharides, and a sulfone group or a carboxyl group has an average of 0.4 to 5 per molecule of the monosaccharide.
Preferably, the molecule is contained, more preferably 0.5 to 3 molecules, still more preferably 0.6 to 2 molecules. The average molecular weight of the polysaccharide of the present invention is preferably 1,000
~ 10,000,000, more preferably 3,000 ~ 1,000,000, even more preferably 5,000 ~ 500,000.

【0004】このような多糖類としては、ヒアルロン
酸、コンドロイチン4-硫酸、コンドロイチン6-硫酸、デ
ルマタン硫酸、ケラタン硫酸、ヘパリン、ヘパリン類似
物質(日本薬局方外医薬品規格収載)、カッパ−、イオ
タ−又はラムダ−カラギーナン、ダービリアエキス等の
酸性ムコ多糖類;キチン等の中性ムコ多糖類を硫酸化し
たものがあげられる。このうち、酸性ムコ多糖類が好ま
しく、特にコンドロイチン4-硫酸、ヘパリン、ヘパリン
類似物質、イオタ−カラギーナン、ヒアルロン酸が好ま
しい。本発明の多糖類は、天然物および合成物に関わら
ず使用でき、単独で使用しても2種以上を併用すること
もできる。本発明の多糖類の配合量は内水相の全質量に
対して好ましくは0.02〜3%、より好ましくは0.2〜2
%、さらに好ましくは0.7〜1.5%である。本発明のW/
O/W型複合エマルションの全質量に対しては、好まし
くは0.01〜2%、より好ましくは0.03〜1.5%、さらに好
ましくは0.05〜1%である。
[0004] Examples of such polysaccharides include hyaluronic acid, chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, keratan sulfate, heparin, heparin-like substances (listed in Japanese Pharmacopoeia outside the Japanese Pharmacopoeia), kappa and iota. Or acid mucopolysaccharides such as lambda-carrageenan and dervillea; and sulfated neutral mucopolysaccharides such as chitin. Of these, acidic mucopolysaccharides are preferred, and chondroitin 4-sulfate, heparin, heparin-like substances, iota-carrageenan, and hyaluronic acid are particularly preferred. The polysaccharide of the present invention can be used irrespective of natural products and synthetic products, and can be used alone or in combination of two or more. The compounding amount of the polysaccharide of the present invention is preferably 0.02 to 3%, more preferably 0.2 to 2%, based on the total mass of the internal aqueous phase.
%, More preferably 0.7 to 1.5%. W / of the present invention
It is preferably 0.01 to 2%, more preferably 0.03 to 1.5%, and still more preferably 0.05 to 1%, based on the total mass of the O / W type composite emulsion.

【0005】本発明の油相としては、流動パラフィン、
ワセリン、マイクロクリスタリンワックス、スクワラン
等の炭化水素類、オリーブ油、サフラワー油、大豆油、
アルモンド油、ヒマシ油等の植物油、ミツロウ、鯨ロ
ウ、ラノリン等の動物性固体ロウ、ミリスチン酸イソプ
ロピル、パルミチン酸イソプロピル、ミリスチン酸オク
チルドデシル、トリ(カプリル・カプリン酸)グリセリ
ン等の脂肪酸エステル等、一般外用剤、化粧品に使用さ
れているものであれば特に限定されることなく使用する
ことができる。本発明のW/O/W型複合エマルション
は、好ましくは以下の方法により製造することができ
る。 1次乳化 分子内にスルホン基及び/又はカルボキシル基を有する
多糖類を含有する内水相成分溶液(好ましくは有効成分
を含有する)と油相成分溶液(好ましくは親油性界面活
性剤を含有する)を、65〜85℃、特に好ましくは7
0〜80℃に加温しそれぞれを均一溶解させる。溶解
後、同温度条件下で油相成分をホモミキサー等で撹拌し
ながら、内水相/油相=50/50〜90/10、好ま
しくは60/40〜85/15、さらに好ましくは65
/35〜80/20の質量比となるように内水相をゆっ
くり添加していきW/O型エマルションを調製する。攪
拌条件は、攪拌羽根の大きさや乳化組成によって適宜選
定されるが、概ね3000〜6000rpmの回転数で
5〜20分間乳化することが好ましい。乳化物の電気伝
導度がほとんどゼロ(外相が油)であることによってW
/O型エマルションの生成を確認する。
[0005] As the oil phase of the present invention, liquid paraffin,
Vaseline, microcrystalline wax, hydrocarbons such as squalane, olive oil, safflower oil, soybean oil,
Vegetable oils such as almond oil and castor oil; animal solid waxes such as beeswax, spermaceti and lanolin; fatty acid esters such as isopropyl myristate, isopropyl palmitate, octyldodecyl myristate, and tri (caprylic / capric acid) glycerin; As long as it is used for external preparations and cosmetics, it can be used without any particular limitation. The W / O / W type composite emulsion of the present invention can be preferably produced by the following method. Primary emulsification An internal aqueous phase component solution (preferably containing an active ingredient) containing a polysaccharide having a sulfone group and / or a carboxyl group in the molecule and an oil phase component solution (preferably containing a lipophilic surfactant) ) At 65-85 ° C, particularly preferably 7
Heat to 0-80 ° C to uniformly dissolve each. After dissolution, the internal water phase / oil phase = 50/50 to 90/10, preferably 60/40 to 85/15, more preferably 65/15 while stirring the oil phase component under the same temperature conditions with a homomixer or the like.
The internal aqueous phase is slowly added so as to have a mass ratio of / 35 to 80/20 to prepare a W / O emulsion. The stirring conditions are appropriately selected depending on the size of the stirring blade and the emulsified composition, but it is preferable to emulsify at a rotation speed of about 3000 to 6000 rpm for 5 to 20 minutes. Since the electric conductivity of the emulsion is almost zero (the external phase is oil), W
Confirm the formation of / O emulsion.

【0006】2次乳化 45〜70℃、特に好ましくは50〜65℃の温度条件
下で外水相溶液(好ましくは親水性界面活性剤を含有す
る)をホモミキサー等で撹拌しながら、で得られたW
/O型エマルションを、W/O型エマルション/外水相
=30/70〜80/20、好ましくは40/60〜7
0/30、さらに好ましくは45/55〜60/40の
質量比となるように外水相に添加していき、W/O/W
型複合エマルションを調製する。乳化条件は、一度生成
した複合粒子が破壊されないよう適宜選定することが好
ましいが、概ね500〜3000rpmの回転数で20
〜90分間乳化することが好ましい。本発明の構成によ
り、内水相を高含水化することが可能である。分散質と
なるW/O型エマルションの内水相と油相の混合質量比
は、内水相/油相=好ましくは50/50〜90/10、より好
ましくは60/40〜85/15、さらに好ましくは70/30〜80
/20が望ましい。この範囲で、好ましい製剤の使用感が
得られるので好ましい。このW/O型エマルションと分散
媒である外水相の質量比は、W/O型エマルション/外水
相=好ましくは30/70〜80/20、より好ましくは40/60
〜70/30、さらに好ましくは45/55〜60/40が望まし
い。この範囲で、本発明のエマルションの生成率および
安定性が良好であるので好ましい。内水相の割合は、本
発明のW/O/W型複合エマルション全体に対して好まし
くは15〜75%、より好ましくは25〜60%、さらに好まし
くは30〜50%が望ましい。内水相と外水相の総量は好ま
しくは70〜95%、より好ましくは75〜93%、さらに好ま
しくは80〜90%が望ましい。この範囲内ではエマルショ
ン化が良好であるので好ましい。なお、本明細書におい
て特に記載しない限り、“%”は質量%を表す。
Secondary emulsification The aqueous emulsion (preferably containing a hydrophilic surfactant) is obtained under stirring at a temperature of 45 to 70 ° C., particularly preferably 50 to 65 ° C., with a homomixer or the like. W
/ O type emulsion, W / O type emulsion / outer aqueous phase = 30 / 70-80 / 20, preferably 40 / 60-7.
0/30, more preferably 45/55 to 60/40 by mass, to the external aqueous phase.
2. Prepare a complex emulsion. The emulsification conditions are preferably selected as appropriate so as not to destroy the composite particles once formed, but are generally 20 rpm at a rotation speed of 500 to 3000 rpm.
It is preferred to emulsify for ~ 90 minutes. According to the configuration of the present invention, it is possible to increase the water content of the internal aqueous phase. The mixing mass ratio of the internal water phase and the oil phase of the W / O emulsion as the dispersoid is such that the internal water phase / the oil phase is preferably 50/50 to 90/10, more preferably 60/40 to 85/15, More preferably 70/30 to 80
/ 20 is desirable. This range is preferable because a feeling of use of the preferred preparation can be obtained. The mass ratio of the W / O emulsion to the external aqueous phase as the dispersion medium is W / O emulsion / external aqueous phase = preferably 30/70 to 80/20, more preferably 40/60.
7070/30, more preferably 45 / 55-60 / 40. This range is preferable because the production rate and stability of the emulsion of the present invention are good. The ratio of the internal aqueous phase is preferably 15 to 75%, more preferably 25 to 60%, and still more preferably 30 to 50%, based on the whole W / O / W composite emulsion of the present invention. The total amount of the inner aqueous phase and the outer aqueous phase is preferably 70 to 95%, more preferably 75 to 93%, and still more preferably 80 to 90%. This range is preferable because the emulsion is good. In this specification, “%” indicates “% by mass” unless otherwise specified.

【0007】本発明のW/O/Wエマルションには、上
記の他、通常W/O/W型複合エマルションに用いられ
る以下の成分を含有することが好ましい。親油性界面活
性剤(1次乳化で用いる乳化剤)として好ましいのは、
グリフィンによるHLBが10以下、より好ましくは7
以下、さらに好ましくは6以下の親油性界面活性剤であ
る。一般外用剤、化粧品に配合され、W/O型エマルショ
ンを形成する親油性界面活性剤を使用することができ
る。例えば、ソルビタン脂肪酸エステル、グリセリン脂
肪酸エステル、プロピレングリコール脂肪酸エステル、
親油性ポリグリセリン脂肪酸エステル、親油性ポリオキ
シエチレンヒマシ油、親油性ポリオキシエチレン硬化ヒ
マシ油、親油性ショ糖脂肪酸エステル等があげられる
が、特にこれらに限定されない。これらのうち、ソルビ
タン脂肪酸エステル、親油性ポリオキシエチレン硬化ヒ
マシ油が好ましい。これらの親油性界面活性剤は単独で
使用しても2種以上を併用してもよい。親油性界面活性
剤の配合量は、その種類や油相成分によって異なるが、
油相に対して好ましくは3〜50%、より好ましくは5〜40
%、W/O/W型複合エマルション全体に対しては好まし
くは1〜10%、より好ましくは2〜8%が望ましい。
[0007] In addition to the above, the W / O / W emulsion of the present invention preferably contains the following components usually used in W / O / W type composite emulsions. Preferred as the lipophilic surfactant (emulsifier used in the primary emulsification)
HLB by Griffin is 10 or less, more preferably 7
Below, more preferably 6 or less lipophilic surfactants. A lipophilic surfactant which is incorporated into general external preparations and cosmetics and forms a W / O emulsion can be used. For example, sorbitan fatty acid ester, glycerin fatty acid ester, propylene glycol fatty acid ester,
Examples include lipophilic polyglycerin fatty acid esters, lipophilic polyoxyethylene castor oil, lipophilic polyoxyethylene hardened castor oil, lipophilic sucrose fatty acid esters, and the like, but are not particularly limited thereto. Of these, sorbitan fatty acid esters and lipophilic polyoxyethylene hydrogenated castor oil are preferred. These lipophilic surfactants may be used alone or in combination of two or more. The amount of the lipophilic surfactant varies depending on the type and the oil phase component,
Preferably 3 to 50%, more preferably 5 to 40% of the oil phase
%, Preferably 1 to 10%, more preferably 2 to 8%, based on the whole W / O / W type composite emulsion.

【0008】親水性界面活性剤(2次乳化で用いる乳化
剤)として、一般外用剤、化粧品に配合され、O/W型エ
マルションを形成する親水性界面活性剤を使用すること
ができる。例えば、ポリオキシエチレンソルビタン脂肪
酸エステル、ポリオキシエチレングリセリン脂肪酸エス
テル、親水性ポリグリセリン脂肪酸エステル、ポリオキ
シエチレンソルビット脂肪酸エステル、親水性ポリオキ
シエチレンヒマシ油、親水性ポリオキシエチレン硬化ヒ
マシ油、ポリオキシエチレンステロール、親水性ポリエ
チレングリコール脂肪酸エステル、親水性ポリオキシエ
チレンアルキルエーテル、ポリオキシエチレンアルキル
フェニルエーテル、ポリオキシエチレンポリオキシプロ
ピレンアルキルエーテル、ポリオキシエチレンポリオキ
シプロピレン重合体、親水性ショ糖脂肪酸エステル等が
あげられるが、特にこれらに限定されない。これらのう
ち、親水性ポリエチレングリコール脂肪酸エステル、親
水性ポリオキシエチレンアルキルエーテルが好ましい。
これらの親水性界面活性剤は、単独で使用しても2種以
上を併用してもよい。親水性界面活性剤の配合量は、そ
の種類や油相成分および親油性界面活性剤の配合量によ
って異なるが、外水相に対して好ましくは0.3〜10%、
より好ましくは0.5〜8%、さらに好ましくは1〜6%、W
/O/W型複合エマルション全体に対しては、好ましくは
0.3〜5%、より好ましくは0.5〜3%が望ましい。このと
きW/O型エマルションの生成に用いた親油性界面活性剤
を可溶化させない範囲内の配合量が必要であり、両者の
配合比は、親油性界面活性剤/親水性界面活性剤=0.5
/1〜20/1、好ましくは0.8/1〜15/1、さらに好まし
くは1/1〜10/1が望ましい。
As the hydrophilic surfactant (emulsifier used in the secondary emulsification), a hydrophilic surfactant which is blended in general external preparations and cosmetics and forms an O / W emulsion can be used. For example, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene glycerin fatty acid ester, hydrophilic polyglycerin fatty acid ester, polyoxyethylene sorbite fatty acid ester, hydrophilic polyoxyethylene castor oil, hydrophilic polyoxyethylene hardened castor oil, polyoxyethylene Sterol, hydrophilic polyethylene glycol fatty acid ester, hydrophilic polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene polyoxypropylene polymer, hydrophilic sucrose fatty acid ester, etc. But are not particularly limited to these. Of these, hydrophilic polyethylene glycol fatty acid esters and hydrophilic polyoxyethylene alkyl ethers are preferred.
These hydrophilic surfactants may be used alone or in combination of two or more. The amount of the hydrophilic surfactant varies depending on the type and the oil phase component and the amount of the lipophilic surfactant, but is preferably 0.3 to 10% based on the external water phase.
More preferably 0.5 to 8%, even more preferably 1 to 6%, W
For the whole / O / W type composite emulsion, preferably
0.3-5%, more preferably 0.5-3% is desirable. At this time, a blending amount within a range that does not solubilize the lipophilic surfactant used for forming the W / O emulsion is required, and the blending ratio of both is lipophilic surfactant / hydrophilic surfactant = 0.5
/ 1 to 20/1, preferably 0.8 / 1 to 15/1, more preferably 1/1 to 10/1.

【0009】本発明は、水相成分に有効成分を含有させ
ることにより、医薬製剤や化粧料に供することができ
る。水溶性の有効成分としては、尿素、グリセリン等の
保湿成分、アスコルビン酸、パントテン酸等のビタミン
類、塩酸ジブカイン、塩酸リドカイン等の局所麻酔剤、
塩酸ジフェンヒドラミン、ホモスルファミン等の抗ヒス
タミン剤、グアイアズレン等の抗炎症成分を挙げること
ができる。異種の水溶性成分を内水相と外水相とそれぞ
れに配合することもできる。有効成分の種類は上記に限
定されるものではなく適宜選択される。また、本発明の
効果を損なわない範囲で、通常外用剤に配合される基剤
成分を必要に応じて適宜配合できる。例えばパラベン
類、安息香酸類、塩化ベンザルコニウム、塩化ベンゼト
ニウム、塩化セチルピリジニウム、塩化アルキルトリメ
チルアンモニウム、クロロブタノール、フェノキシエタ
ノール等の防腐剤、トコフェロール、エリソルビン酸、
没食子酸プロピル、BHT、BHA、NDGA等の抗酸
化剤、香料を挙げることができる。
The present invention can be used for pharmaceutical preparations and cosmetics by adding an active ingredient to the aqueous phase component. Examples of water-soluble active ingredients include humectants such as urea and glycerin, vitamins such as ascorbic acid and pantothenic acid, local anesthetics such as dibucaine hydrochloride and lidocaine hydrochloride,
Examples include antihistamines such as diphenhydramine hydrochloride and homosulfamine, and anti-inflammatory components such as guaiazulene. Different water-soluble components can be blended into the inner aqueous phase and the outer aqueous phase, respectively. The type of the active ingredient is not limited to the above, and may be appropriately selected. In addition, a base component that is usually compounded in an external preparation can be appropriately compounded as needed within a range not to impair the effects of the present invention. For example, parabens, benzoic acids, benzalkonium chloride, benzethonium chloride, cetylpyridinium chloride, alkyltrimethylammonium chloride, chlorobutanol, preservatives such as phenoxyethanol, tocopherol, erythorbic acid,
Examples include antioxidants such as propyl gallate, BHT, BHA, and NDGA, and fragrances.

【0010】[0010]

【実施例】下記の表1〜4に示した実施例及び比較例の
組成でW/O/W型複合エマルションを調製し、その生成
率と各温度領域における保存安定性、および得られたW
/O/W型複合エマルションの使用感を評価した。 (調製法)内水相、油相、外水相を個別に調製し、それ
ぞれを70℃〜80℃に加温攪拌し、均一に溶解させ
た。70℃〜80℃の温度下でホモミキサーを用いて40
00 rpm〜5000 rpmで油相を攪拌しながら、内水相をゆっ
くり添加していき、5〜10分間乳化し、W/O型エマルシ
ョンを得た。続いて外水相を500〜1000 rpmで攪拌しな
がら、該W/O型エマルションをゆっくり添加していき3
0〜60分間乳化し、W/O/W型複合エマルションを得
た。 (生成率)W/O/W生成率(%)は、マーカー物質とし
て塩化カリウムを内水相に配合してエマルションを調製
後、透析により外水相に存在する塩素イオン濃度をイオ
ンメーターで測定し求めた。生成率100%とは、マーカ
ー物質がすべて内水相中に封入された状態であり、生成
率0%とは、マーカー物質がすべて外水相に移行しO/W
型の転相した状態である。生成率は、下記の5段階で評
価し、◎○△を高い生成率と判断した。(生成率(%):8
5%以上:◎、70〜85%:○、60〜70%:△、50〜60
%:▲、50%未満:×、エマルション化不可:−)
EXAMPLES W / O / W type composite emulsions were prepared according to the compositions of Examples and Comparative Examples shown in Tables 1 to 4 below, and their production rates, storage stability in various temperature ranges, and obtained W were obtained.
The feeling of use of the / O / W type composite emulsion was evaluated. (Preparation method) An inner aqueous phase, an oil phase, and an outer aqueous phase were individually prepared, and each was heated and stirred at 70 ° C to 80 ° C and uniformly dissolved. Using a homomixer at a temperature of 70 ° C to 80 ° C, 40
While stirring the oil phase at 00 rpm to 5000 rpm, the internal aqueous phase was slowly added and emulsified for 5 to 10 minutes to obtain a W / O emulsion. Subsequently, the W / O emulsion was slowly added while stirring the outer aqueous phase at 500 to 1000 rpm.
The mixture was emulsified for 0 to 60 minutes to obtain a W / O / W type composite emulsion. (Production rate) The W / O / W production rate (%) is determined by mixing potassium chloride as a marker substance in the internal aqueous phase to prepare an emulsion, and then measuring the concentration of chloride ions present in the external aqueous phase by dialysis using an ion meter. I asked. A production rate of 100% is a state in which all the marker substances are encapsulated in the internal aqueous phase, and a production rate of 0% means that all of the marker substances migrate to the external aqueous phase and the O / W
This is a state in which the mold has undergone phase inversion. The production rate was evaluated according to the following five grades, and ◎ was judged to be a high production rate. (Generation rate (%): 8
5% or more: ◎, 70-85%: ○, 60-70%: △, 50-60
%: ▲, less than 50%: ×, emulsion not possible:-)

【0011】(安定性)保存安定性は、調製したエマルシ
ョンをスクリューキャップ付きサンプル管に入れ、所定
条件下で保存後、状態を観察し評価した。安定性は、下
記の5段階で評価し、◎○△を安定なレベルと判断し
た。(保存安定性:変化なし:◎、やや粘度低下:○、
粘度低下:△、表面に僅かに油しみだし:▲、相分離:
×) なお、凍結復元性の評価は、エマルションを−20℃に
1日保存し凍結させた後、室温に3日間静置し、状態を
観察して評価した。 (使用感)下記の実施例および比較例のW/O/W型複合エ
マルションについて、20人のパネラーに対して使用テス
トを実施した。方法は、20℃/50%RHの恒温恒湿
下で15分間安静にした後、前腕内側に所定量(0.5
mL)の検体を塗布し、塗布時ののびの良さ、肌へのな
じみの良さ、塗布後のさっぱり感、べたつき感のなさ、
総合評価の5項目について5段階で評点付けし、20人の合
計点で評価した。(各項目の評価基準:非常に良好:5
点、良好:4点、普通:3点、悪い2点、非常に悪い:1
点) 使用感は、下記の5段階で評価し、◎○△を良好な使用
感と判断した。(使用感点数評価:85点以上:◎、70〜
85点:○、60〜70点:△、50〜60点:▲、50点未満:
×)
(Stability) The storage stability was evaluated by placing the prepared emulsion in a sample tube equipped with a screw cap, storing the emulsion under predetermined conditions, and observing the condition. The stability was evaluated on the following five levels, and △ ○ △ was judged to be a stable level. (Storage stability: no change: 、, slightly reduced viscosity: 、,
Decrease in viscosity: △, slight oil seepage on the surface: ▲, phase separation:
X) In addition, the evaluation of freeze-recoverability was performed by storing the emulsion at -20 ° C for 1 day, freezing it, leaving it at room temperature for 3 days, and observing the state. (Feeling of use) With respect to the W / O / W type composite emulsions of the following Examples and Comparative Examples, use tests were conducted on 20 panelists. The method is as follows: after resting for 15 minutes under constant temperature and humidity of 20 ° C./50% RH, a predetermined amount (0.5
mL) of the sample, spread it when applying, good fit to the skin, freshness after application, non-stickiness,
The five items of the comprehensive evaluation were rated on a five-point scale, with a total score of 20 people. (Evaluation criteria for each item: very good: 5
Point, good: 4 points, normal: 3 points, 2 bad points, very bad: 1 point
Point) The usability was evaluated on the following five levels, and △ ○ △ was judged to be a good usability. (Evaluation of usability score: 85 points or more: ◎, 70 ~
85 points: ○, 60-70 points: △, 50-60 points: ▲, less than 50 points:
×)

【0012】[0012]

【表1】 [Table 1]

【0013】[0013]

【表2】 [Table 2]

【0014】[0014]

【表3】 [Table 3]

【0015】[0015]

【表4】 [Table 4]

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C08J 3/03 CEP C08K 5/00 3/075 CEP C08J 3/03 CEP C08K 5/00 Fターム(参考) 4C076 AA18 BB31 EE30F FF16 GG45 4C083 AC022 AC072 AC122 AC242 AC352 AC402 AC442 AC482 AD211 AD311 AD312 AD341 AD352 CC01 DD34 FF05 4F070 CA02 CB01 CB04 4J002 AB00W AB05W AE00X DE026 EH037 EH047 FD20X FD206 FD207 GB00 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C08J 3/03 CEP C08K 5/00 3/075 CEP C08J 3/03 CEP C08K 5/00 F term (reference) 4C076 AA18 BB31 EE30F FF16 GG45 4C083 AC022 AC072 AC122 AC242 AC352 AC402 AC442 AC482 AD211 AD311 AD312 AD341 AD352 CC01 DD34 FF05 4F070 CA02 CB01 CB04 4J002 AB00W AB05W AE00X DE026 EH037 FD0207 FD0206 FD

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 分子内にスルホン基及び/又はカルボキ
シル基を有する多糖類を内水相に含有することを特徴と
するW/O/W型複合エマルション。
1. A W / O / W type composite emulsion comprising a polysaccharide having a sulfone group and / or a carboxyl group in a molecule in an internal aqueous phase.
【請求項2】 前記多糖類が酸性ムコ多糖である請求項
1記載のW/O/W型複合エマルション。
2. The polysaccharide is an acid mucopolysaccharide.
2. The W / O / W composite emulsion according to 1.
【請求項3】 分子内にスルホン基及び/又はカルボキ
シル基を有する多糖類を含有する内水相/油相=50/
50〜90/10(質量比)であることを特徴とする請
求項1又は2記載のW/O/W型複合エマルション。
3. An internal water phase / oil phase containing a polysaccharide having a sulfone group and / or a carboxyl group in a molecule = 50 /
3. The W / O / W type composite emulsion according to claim 1, wherein the weight ratio is 50 to 90/10 (mass ratio).
【請求項4】 分子内にスルホン基及び/又はカルボキ
シル基を有する多糖類を含有する内水相と油相からなる
W/O型エマルション/外水相=30/70〜80/2
0(質量比)であることを特徴とする請求項1〜3いず
れか1項記載のW/O/W型複合エマルション。
4. A W / O emulsion comprising an inner aqueous phase and an oil phase containing a polysaccharide having a sulfone group and / or a carboxyl group in the molecule / outer aqueous phase = 30 / 70-80 / 2.
The W / O / W type composite emulsion according to any one of claims 1 to 3, wherein 0 (mass ratio).
JP33735099A 1999-11-29 1999-11-29 W / O / W type composite emulsion Expired - Fee Related JP4478264B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP33735099A JP4478264B2 (en) 1999-11-29 1999-11-29 W / O / W type composite emulsion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33735099A JP4478264B2 (en) 1999-11-29 1999-11-29 W / O / W type composite emulsion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009053630A Division JP4731610B2 (en) 2009-03-06 2009-03-06 W / O / W type composite emulsion

Publications (2)

Publication Number Publication Date
JP2001151938A true JP2001151938A (en) 2001-06-05
JP4478264B2 JP4478264B2 (en) 2010-06-09

Family

ID=18307803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP33735099A Expired - Fee Related JP4478264B2 (en) 1999-11-29 1999-11-29 W / O / W type composite emulsion

Country Status (1)

Country Link
JP (1) JP4478264B2 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043698A1 (en) * 2000-11-29 2002-06-06 Taisho Pharmaceutical Co.,Ltd. W/o/w composite emulsion
WO2002043697A1 (en) * 2000-11-29 2002-06-06 Taisho Pharmaceutical Co.,Ltd. W/o/w composite emulsion
JP2003040765A (en) * 2001-07-23 2003-02-13 Lion Corp W/o/w type double emulsion
JP2005097292A (en) * 2003-09-01 2005-04-14 Taisho Pharmaceut Co Ltd W/o/w type double emulsion
JP2007519506A (en) * 2003-11-13 2007-07-19 ロディア・シミ Emulsions for transporting hydrophobic active materials to substrates in aqueous media
CN113831551A (en) * 2021-10-13 2021-12-24 江苏集萃新型药物制剂技术研究所有限公司 Aqueous dispersion

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043698A1 (en) * 2000-11-29 2002-06-06 Taisho Pharmaceutical Co.,Ltd. W/o/w composite emulsion
WO2002043697A1 (en) * 2000-11-29 2002-06-06 Taisho Pharmaceutical Co.,Ltd. W/o/w composite emulsion
US6984691B2 (en) 2000-11-29 2006-01-10 Taisho Pharmaceutical Co., Ltd. W/O/W composite emulsion
JP2003040765A (en) * 2001-07-23 2003-02-13 Lion Corp W/o/w type double emulsion
JP2005097292A (en) * 2003-09-01 2005-04-14 Taisho Pharmaceut Co Ltd W/o/w type double emulsion
JP2007519506A (en) * 2003-11-13 2007-07-19 ロディア・シミ Emulsions for transporting hydrophobic active materials to substrates in aqueous media
CN113831551A (en) * 2021-10-13 2021-12-24 江苏集萃新型药物制剂技术研究所有限公司 Aqueous dispersion

Also Published As

Publication number Publication date
JP4478264B2 (en) 2010-06-09

Similar Documents

Publication Publication Date Title
JP5101808B2 (en) Oil-in-water liquid composition
JP2554880B2 (en) Skin cosmetics
JP2000234085A (en) Associative thickener and thickening composition
KR102245838B1 (en) Low viscosity cosmetic composition having excelllent emulsion stability
WO1999040887A1 (en) Oil-in-water type emulsified compositions
JP3623408B2 (en) Stable gelled aqueous composition containing a large amount of electrolyte
JP2003095956A (en) Microemulsion composition
JP2006290762A (en) Oil-in-water emulsified composition
JP2003292414A (en) Liposoluble component-stabilized composition and cosmetic formulated with the composition and method for stabilizing liposoluble component
WO2001070271A2 (en) Acid-stable base compositions for preparing surfactant free topical compositions
JP4478264B2 (en) W / O / W type composite emulsion
JPH06219923A (en) Transparent liquid composition
JP2944258B2 (en) Emulsion type cosmetic
KR20120031879A (en) Emulsion composition
JP6792353B2 (en) Water-in-oil emulsified composition
JPS58183938A (en) Emulsified composition
CN115518030A (en) Preparation method of dimethicone cream
JP2002205937A (en) Emulsified composition
JP6726498B2 (en) External composition
JP4731610B2 (en) W / O / W type composite emulsion
JP2006307037A (en) W/o/w type emulsion composition
KR20140094187A (en) Surfactant-free self-foaming cosmetic composition
JP6450144B2 (en) Liposomes and liposome-containing cosmetics
JP6640556B2 (en) Oil-in-water liquid bath agent and method for producing the same
JP2001354820A (en) Composite emulsion and cosmetic formulated with the emulsion

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060801

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20081222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090105

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090306

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100304

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100315

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4478264

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130319

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140319

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees